MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
06 2019
Historique:
received: 18 04 2018
accepted: 04 04 2019
pubmed: 28 5 2019
medline: 10 7 2019
entrez: 29 5 2019
Statut: ppublish

Résumé

The histone acetyl reader bromodomain-containing protein 4 (BRD4) is an important regulator of chromatin structure and transcription, yet factors modulating its activity have remained elusive. Here we describe two complementary screens for genetic and physical interactors of BRD4, which converge on the folate pathway enzyme MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1). We show that a fraction of MTHFD1 resides in the nucleus, where it is recruited to distinct genomic loci by direct interaction with BRD4. Inhibition of either BRD4 or MTHFD1 results in similar changes in nuclear metabolite composition and gene expression; pharmacological inhibitors of the two pathways synergize to impair cancer cell viability in vitro and in vivo. Our finding that MTHFD1 and other metabolic enzymes are chromatin associated suggests a direct role for nuclear metabolism in the control of gene expression.

Identifiants

pubmed: 31133746
doi: 10.1038/s41588-019-0413-z
pii: 10.1038/s41588-019-0413-z
pmc: PMC6952269
mid: EMS82532
doi:

Substances chimiques

BRD4 protein, human 0
Cell Cycle Proteins 0
Chromatin 0
Minor Histocompatibility Antigens 0
Nuclear Proteins 0
Transcription Factors 0
Folic Acid 935E97BOY8
MTHFD1 protein, human EC 1.5.1.5
Methylenetetrahydrofolate Dehydrogenase (NADP) EC 1.5.1.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

990-998

Subventions

Organisme : European Research Council
ID : 772437
Pays : International

Références

Nat Commun. 2015 Mar 03;6:6285
pubmed: 25734337
Mol Cell. 2016 Apr 7;62(1):34-46
pubmed: 27058786
BMC Bioinformatics. 2014 Jun 12;15:182
pubmed: 24925680
Science. 2018 Jul 27;361(6400):412-415
pubmed: 29930094
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2319-E2326
pubmed: 28265077
Nature. 2014 Jun 12;510(7504):278-82
pubmed: 24759320
Nature. 2015 Sep 24;525(7570):538-42
pubmed: 26367796
Nat Rev Mol Cell Biol. 2018 Sep;19(9):563-578
pubmed: 29930302
Genes Dev. 2016 Nov 1;30(21):2345-2369
pubmed: 27881599
Annu Rev Nutr. 2018 Aug 21;38:219-243
pubmed: 30130467
Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Nat Methods. 2013 Oct;10(10):965-71
pubmed: 24161985
Nature. 2015 Sep 24;525(7570):543-547
pubmed: 26367798
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Nature. 2017 Jun 15;546(7658):381-386
pubmed: 28562591
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Nature. 2016 Jan 21;529(7586):413-417
pubmed: 26735014
Science. 2018 Jul 27;361(6400):
pubmed: 29930091
Cell Metab. 2017 Mar 7;25(3):544-558
pubmed: 28273477
Biochimie. 2016 Jul;126:27-30
pubmed: 26853819
Mol Cell. 2017 Jul 6;67(1):5-18.e19
pubmed: 28673542
Nature. 2011 Oct 02;478(7370):529-33
pubmed: 21964340
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Expert Opin Ther Pat. 2014 Jun;24(6):687-97
pubmed: 24655343
Nat Genet. 2014 Apr;46(4):364-70
pubmed: 24584072
Experientia. 1973 May 1;29(1):39-40
pubmed: 4729447
Nature. 2013 Jun 13;498(7453):246-50
pubmed: 23728299
Trends Biochem Sci. 2016 Aug;41(8):712-730
pubmed: 27345518
Nat Commun. 2018 Oct 2;9(1):4048
pubmed: 30279501
J Biol Chem. 2014 Oct 24;289(43):29642-50
pubmed: 25213861
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Nat Biotechnol. 2011 May 29;29(6):542-6
pubmed: 21623355
Nature. 2011 Aug 03;478(7370):524-8
pubmed: 21814200
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Nature. 2010 Dec 23;468(7327):1067-73
pubmed: 20871596
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nature. 2005 Aug 11;436(7052):876-80
pubmed: 15988478
Chem Sci. 2017 Jun 1;8(6):4250-4256
pubmed: 28626565
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nat Chem Biol. 2016 Jul;12(7):504-10
pubmed: 27159579
J Biol Chem. 2011 Dec 23;286(51):44015-22
pubmed: 22057276
Science. 2009 Nov 27;326(5957):1231-5
pubmed: 19965467
Science. 2015 Jun 26;348(6242):1481-1485
pubmed: 26022416
Mol Cell. 2014 Jun 5;54(5):728-36
pubmed: 24905006
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Nat Rev Clin Oncol. 2014 May;11(5):282-98
pubmed: 24732946
Annu Rev Biochem. 2012;81:119-43
pubmed: 22404626
Cell. 2012 Mar 30;149(1):214-31
pubmed: 22464331
Science. 2016 Jun 3;352(6290):1221-5
pubmed: 27257257
Science. 2015 Jun 19;348(6241):1376-81
pubmed: 25999370
Nat Rev Drug Discov. 2014 May;13(5):337-56
pubmed: 24751816

Auteurs

Sara Sdelci (S)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

André F Rendeiro (AF)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Philipp Rathert (P)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Biochemistry Department, University Stuttgart, Stuttgart, Germany.

Wanhui You (W)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Jung-Ming G Lin (JG)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Anna Ringler (A)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Gerald Hofstätter (G)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Herwig P Moll (HP)

Department of Physiology, Center of Physiology and Pharmacology & Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Bettina Gürtl (B)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Matthias Farlik (M)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Sandra Schick (S)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Freya Klepsch (F)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Matthew Oldach (M)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Pisanu Buphamalai (P)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Fiorella Schischlik (F)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Peter Májek (P)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Katja Parapatics (K)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Christian Schmidl (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Medical Center, Regensburg, Germany.

Michael Schuster (M)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Thomas Penz (T)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Dennis L Buckley (DL)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Otto Hudecz (O)

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.

Richard Imre (R)

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.

Shuang-Yan Wang (SY)

Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, Würzburg, Germany.
Institute of Structural Biology, Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.

Hans Michael Maric (HM)

Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, Würzburg, Germany.
Institute of Structural Biology, Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.

Robert Kralovics (R)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Keiryn L Bennett (KL)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Andre C Müller (AC)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Karl Mechtler (K)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.

Jörg Menche (J)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

James E Bradner (JE)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Georg E Winter (GE)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Kristaps Klavins (K)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Emilio Casanova (E)

Department of Physiology, Center of Physiology and Pharmacology & Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.

Christoph Bock (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Max Planck Institute for Informatics, Saarbrücken, Germany.

Johannes Zuber (J)

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.

Stefan Kubicek (S)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. skubicek@cemm.oeaw.ac.at.
Department of Physiology, Center of Physiology and Pharmacology & Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. skubicek@cemm.oeaw.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH